Bosentan 68180-0340
Product NDC
68180-0340- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 18, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA213154
Need to source Bosentan? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bosentan | 32 mg/1 |
Drug Class
Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A Inducers [MoA]Endothelin Receptor Antagonist [EPC]
Packaging Options(1)
4 BLISTER PACK in 1 CARTON (68180-340-13) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK